Voyager Therapeutics Income Statement (2015-2025) | VYGR

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 2.58M4.88M4.94M4.94M4.83M3.72M3.31M2.36M1.46M1.18M1.15M6.35M0.94M2.58M2.09M2.01M5.20M46.09M20.43M32.67M18.07M28.68M117.84M6.54M6.50M1.36M1.48M28.07M0.66M0.71M41.09M-1.55M150.48M4.90M4.61M90.06M19.52M29.60M24.63M6.28M6.50M5.20M13.40M
Operating items
Research & Development 5.52M6.46M6.48M9.22M8.73M10.48M10.31M12.72M14.07M15.30M19.56M13.33M14.85M16.51M16.63M16.91M24.83M28.58M29.78M36.55M32.29M29.42M25.04M22.00M22.35M19.50M17.91M14.02M14.35M12.53M19.34M14.55M18.57M21.98M25.86M25.76M27.09M34.45M30.24M35.58M31.53M31.33M35.87M
Selling, General & Administrative 1.88M2.40M2.48M3.16M3.56M2.85M3.37M3.48M4.91M4.52M4.94M5.37M7.18M11.76M6.61M8.26M9.66M8.32M8.46M9.89M10.21M8.24M8.28M8.27M9.74M10.44M8.71M8.35M7.66M7.55M7.31M8.46M9.03M8.29M8.26M10.24M8.61M10.15M8.17M8.99M9.64M10.49M8.09M
Other Operating Expenses 0.00M
Operating Expenses 7.40M8.85M8.96M12.38M12.30M13.34M13.68M16.20M18.99M19.82M24.50M18.69M22.04M28.27M23.24M25.17M34.49M36.90M38.24M46.44M42.50M37.66M33.32M30.27M32.09M29.94M26.63M22.37M22.01M20.08M26.64M23.01M27.60M30.28M34.12M36.00M35.70M44.60M38.41M44.58M41.17M41.83M43.96M
Operating Income -4.83M-3.97M-4.02M-7.44M-7.47M-9.62M-10.37M-13.84M-17.52M-18.64M-23.36M-12.35M-21.09M-25.69M-21.15M-23.16M-29.29M9.19M-17.81M-13.77M-24.43M-8.98M84.53M-23.73M-25.59M-28.59M-25.15M5.70M-21.35M-19.37M14.44M-24.56M122.88M-25.43M-29.51M54.06M-16.18M-15.03M-13.78M-38.30M-34.69M-36.62M-30.59M
EBIT -4.83M-3.97M-4.02M-7.44M-7.47M-9.62M-10.37M-13.84M-17.52M-18.64M-23.36M-12.35M-21.09M-25.69M-21.15M-23.16M-29.29M9.19M-17.81M-13.77M-24.43M-8.98M84.53M-23.73M-25.59M-28.59M-25.15M5.70M-21.35M-19.37M14.44M-24.56M122.88M-25.43M-29.51M54.06M-16.18M-15.03M-13.78M-38.30M-34.69M-36.62M-30.59M
Non-operating items
Interest & Investment Income 0.10M0.16M0.47M0.43M1.17M-1.09M0.25M0.26M0.29M0.43M0.59M0.87M0.94M0.91M1.15M2.10M1.82M1.39M0.98M0.35M0.25M0.08M0.02M0.05M0.12M-0.64M0.03M0.22M0.55M0.98M1.86M3.27M3.43M3.15M4.87M4.89M4.58M3.99M3.29M2.83M2.38M
Other Non Operating Income -0.19M-0.15M-0.10M0.62M0.40M-0.30M-0.28M0.12M0.40M-0.72M-0.08M-0.28M0.98M-0.13M0.98M-0.20M-0.81M-0.05M0.83M7.72M3.92M-1.58M-0.11M0.65M-0.02M2.64M-0.02M0.20M0.40M0.42M0.43M0.40M
Non Operating Income 0.10M0.28M0.28M1.07M-0.48M0.65M-0.30M-0.28M0.55M0.99M-0.72M0.86M0.63M2.12M1.96M2.80M1.19M-0.81M0.30M1.08M7.80M3.94M-1.58M-0.11M0.40M0.03M0.28M3.18M0.95M1.86M3.28M3.43M3.15M4.87M4.91M4.78M4.40M3.71M3.26M2.79M
Net income details
EBT -14.58M-3.90M-3.92M-7.28M-7.19M-9.34M-9.30M-14.32M-16.87M-18.68M-23.35M-11.80M-20.11M-25.54M-20.29M-22.53M-27.17M11.15M-15.01M-12.57M-23.45M-8.63M84.78M-23.65M-25.57M-28.54M-25.02M5.06M-21.32M-19.09M17.62M-23.61M124.75M-22.15M-26.08M57.22M-11.32M-10.12M-9.00M-33.90M-30.98M-33.37M-27.81M
Tax Provisions -0.30M0.35M-0.23M0.20M-0.18M0.70M0.06M-0.18M0.82M0.01M0.02M0.04M0.58M0.04M0.01M0.08M
Profit After Tax -14.58M-3.90M-3.92M-7.28M-7.19M-9.34M-9.00M-14.67M-16.65M-18.88M-23.35M-11.83M-19.93M-25.54M-20.29M-22.53M-27.17M11.15M-15.01M-12.57M-24.26M-8.68M85.61M-15.93M-21.65M-30.12M-25.14M5.71M-21.32M-19.09M17.62M-23.63M124.04M-22.21M-25.90M56.40M-11.33M-10.14M-9.04M-34.49M-31.02M-33.38M-27.89M
Income from Continuing Operations -14.58M-3.90M-3.92M-7.28M-7.19M-9.34M-9.00M-14.67M-16.65M-18.88M-23.35M-11.80M-19.93M-25.54M-20.29M-22.53M-27.17M11.15M-15.01M-12.57M-23.45M-8.63M84.78M-23.65M-25.57M-28.54M-25.02M5.06M-21.32M-19.09M17.62M-23.61M124.04M-22.21M-25.90M56.40M-11.33M-10.14M-9.04M-34.49M-31.02M-33.38M-27.89M
Consolidated Net Income -14.58M-3.90M-3.92M-7.28M-7.19M-9.34M-9.00M-14.67M-16.65M-18.88M-23.35M-11.80M-19.93M-25.54M-20.29M-22.53M-27.17M11.15M-15.01M-12.57M-23.45M-8.63M84.78M-23.65M-25.57M-28.54M-25.02M5.06M-21.32M-19.09M17.62M-23.61M124.04M-22.21M-25.90M56.40M-11.33M-10.14M-9.04M-34.49M-31.02M-33.38M-27.89M
Income towards Parent Company -14.58M-3.90M-3.92M-7.28M-7.19M-9.34M-9.00M-14.67M-16.65M-18.88M-23.35M-11.80M-19.93M-25.54M-20.29M-22.53M-27.17M11.15M-15.01M-12.57M-23.45M-8.63M84.78M-23.65M-25.57M-28.54M-25.02M5.06M-21.32M-19.09M17.62M-23.61M124.04M-22.21M-25.90M56.40M-11.33M-10.14M-9.04M-34.49M-31.02M-33.38M-27.89M
Preferred Dividend Payments 1.00M2.45M2.59M1.33M
Net Income towards Common Stockholders -15.81M-6.75M-6.91M-8.82M-7.19M-9.34M-9.00M-14.67M-16.65M-18.88M-23.35M-11.80M-19.93M-19.93M-20.29M-22.53M-27.17M-27.17M-15.01M-12.57M-23.45M-8.63M85.61M-15.93M-25.57M-28.54M-25.14M5.71M-21.32M-19.09M17.62M-23.63M124.04M-22.21M-25.90M56.40M-11.33M-10.14M-9.04M-34.49M-31.02M-33.38M-27.89M
Additional items
EPS (Basic) 15.815.805.250.670.290.370.350.57-0.65-0.73-0.89-0.40-0.63-0.80-0.63-0.70-0.810.30-0.41-0.34-0.66-0.232.30-0.43-0.58-0.80-0.670.15-0.56-0.500.46-0.623.05-0.51-0.591.23-0.20-0.18-0.16-0.60-0.53-0.57-0.47
EPS (Weighted Average and Diluted) -0.63-0.75-0.41-0.34-0.662.27-0.42-0.58-0.80-0.670.15-0.56-0.500.45-0.622.94-0.51-0.591.19-0.20-0.18-0.16-0.60-0.53-0.57-0.47
Shares Outstanding (Weighted Average) 25.72M26.75M26.75M26.75M26.75M26.73M26.72M26.85M26.85M26.90M26.95M32.21M32.32M32.44M32.56M32.62M36.83M36.93M37.07M37.15M37.19M37.43M37.47M37.65M37.73M37.96M37.96M38.11M38.46M38.65M38.61M43.29M43.54M43.90M44.00M54.30M54.39M54.53M54.63M55.21M55.34M55.47M
Shares Outstanding (Diluted Average) 37.94M37.03M37.50M37.58M38.05M38.30M57.12M57.72M57.85M58.35M58.67M58.80M
EBITDA -14.58M-3.92M-3.86M-7.57M-6.91M-9.30M-8.43M-15.36M-16.27M-19.17M-23.83M-11.66M-19.80M-25.50M-20.34M-22.61M-27.11M11.33M-15.12M-12.66M-23.74M-8.96M85.41M-16.00M-21.64M-30.12M-25.14M5.70M-21.40M-19.23M17.65M-23.51M124.13M-22.21M-26.02M56.59M-11.79M-10.16M-8.55M-34.86M-30.81M-33.40M-27.66M
Interest Expenses 9.75M-0.07M-0.10M-0.28M-0.28M
Tax Rate 3.26%1.34%0.90%0.56%0.68%1.44%